Clinical Trial Update: Study Comparing Lapatinib (GW572016) And Letrozole Versus Letrozole In Subjects With Advanced Or Metastatic Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing lapatinib plus letrozole to letrozole alone in advanced/metastatic breast cancer completed; results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Lapatinib (Lapatinib)
• Letrozole (letrozole)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Breast Neoplasms | Phase 3 | Status: COMPLETED | Results posted: 2012-05-17